Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$17,900,294
+$5,210,228 QoQ
Shares Held
14,924
+8.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#942
of 4,605 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$2,039,031
CallShares
1,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HUB Investment Partners, LLC holds $120,989,044 across 14 Drug Manufacturers - General names. LLY ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
158,806 | $39,961,941 | |
| 2 | JNJ |
Johnson & Johnson
|
72,119 | $18,316,062 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
14,924 | $17,900,294 | |
| 4 | AZN |
Astrazeneca PLC
|
78,626 | $14,909,062 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
87,005 | $10,992,211 | |
| 6 | MRK |
Merck & Co., Inc.
|
51,940 | $6,674,290 | |
| 7 | PFE |
Pfizer Inc
|
197,054 | $4,745,060 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
39,485 | $2,275,125 |
All Filings in LLY
Export CSV
37 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,900,294 | 14,924 | Shares | Sole | 2026-07-31 | |
| 2026-06-30 | $2,039,031 | 1,700 | Call | Sole | 2026-07-31 | |
| 2026-03-31 | $12,690,066 | 13,797 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $367,908 | 400 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $2,256,828 | 2,100 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $13,629,093 | 12,682 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $1,289,616 | 1,200 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $8,957,620 | 11,740 | Shares | Sole | 2025-11-12 | |
| 2025-09-30 | $1,220,800 | 1,600 | Call | Sole | 2025-11-12 | |
| 2025-06-30 | $1,403,154 | 1,800 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $935,436 | 1,200 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $9,296,674 | 11,926 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $743,319 | 900 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $9,549,997 | 11,563 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $182,562 | 1,400 | Call | Sole | 2025-02-11 | |
| 2024-12-31 | $11,009,492 | 14,261 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $442,970 | 500 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $18,249,478 | 20,599 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $362,152 | 400 | Call | Sole | 2024-08-09 | |
| 2024-06-30 | $6,640,056 | 7,334 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,100,492 | 2,700 | Call | Sole | 2024-05-10 | |
| 2024-03-31 | $1,166,940 | 1,500 | Put | Sole | 2024-05-10 | |
| 2024-03-31 | $4,747,889 | 6,103 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,537,740 | 9,500 | Call | Sole | 2024-02-06 | |
| 2023-12-31 | $2,744,387 | 4,708 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,619,318 | 8,600 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $1,803,145 | 3,357 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,627,829 | 3,471 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,155,608 | 3,365 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,089,837 | 2,979 | Shares | Sole | 2023-02-10 | |
| 2022-12-31 | $7,316,800 | 20,000 | Call | Sole | 2023-02-10 | |
| 2022-09-30 | $849,440 | 2,627 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $532,385 | 1,642 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $693,588 | 2,422 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $502,444 | 1,819 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $405,492 | 1,755 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $395,233 | 1,722 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||